Breaking News on Supplements & Nutrition - North AmericaEU edition

NDI draft guidance

The Food and Drug Administration (FDA) has issued its long awaited draft guidance for new dietary ingredients (NDI), and the industry in general is not happy. NutraIngredients-USA has collected analysis and insights from the leading players in the industry, from the trade associations to leading manufacturers and the FDA itself.

Burcon president Johann Tergesen: “It can be a real challenge to move the industry to adopt new and innovative ingredients.”

Plant proteins, ‘pill fatigue’ and ‘abominable’ weight loss ads: A year in supplements…

Could 2012 be the year for canola protein to shine? Will a dietary solution to the ticking time bomb of type 2 diabetes finally make it big in the supplement...

ABC: Solvents white paper could help inform NDI debate

An authoritative new guide to 23+solvents used in the production of botanical extracts for dietary ingredients could help inform the debate on ‘chemical alteration’ at the heart of the FDA’s...

John Gay: We will have to seriously consider taking the fight to Capitol Hill or the courts if FDA does not substantially revise its draft guidance on NDIs

The agony and the ecstasy: A year in the life of the trade association…

Not surprisingly, the FDA's draft guidance on new dietary ingredients (NDIs) is top of the list for most trade associations when asked what is keeping them awake at night as...

USPLabs says the DMAA in OxyELITE Pro and Jack3d products is derived from the geranium plant

USPLabs hit with class action over DMAA in Jack3d and OxyELITE

The regulatory status and safety of DMAA, a stimulant used in sports and weight loss supplements and reported by some to be a natural constituent of geranium oil, has been...

News in brief

Ullman: NDI draft guidance withdrawal unlikely, but industry deserves timely response

While it is possible that the FDA could withdraw its draft guidance on new dietary ingredients (NDIs), such a move would be “highly unusual”, according to one leading food law...

Jarrow Rogovin: Draft NDI guidance is "truly an escort to the guillotine for the supplement industry”

Jarrow: FDA's talk of spiked supplements in context of NDI debate is 'highly disingenuous'

Food and Drug Administration (FDA) references to safety concerns over supplements spiked with drugs in the context of the debate on new dietary ingredients (NDIs) are “highly disingenuous”, Jarrow Formulas...

News in brief

UNPA webinar to explore NDIs ‘what now?’ with FDA

The United Natural Products Alliance (UNPA) will host a webinar on Wednesday December 21 with FDA’s Daniel Fabricant, PhD, to discuss the 7,000+ comments filed on the new dietary ingredients...

Ashish Talati: Ingredient manufacturers may not wish to provide information that they have developed at great expense to finished product manufacturers...
NDI draft guidance comments

Lawyer: NDI draft guidance raises ‘significant intellectual property issues’

Requiring supplement manufacturers to submit new dietary ingredient (NDI) notifications will force them to seek confidential information from suppliers in order to file submissions, according to law firm Amin Talati.

NDI comments review: Industry urges FDA back to the drawing board

One week on from the deadline for submission of comments on the FDA’s new dietary ingredients (NDI) draft guidance, we review the comments.

NDI draft guidance comments

IPA: We do not see NDI draft guidance as 'death sentence' for probiotics industry

The only probiotics that should be subject to new dietary ingredient (NDI) notifications should be “new probiotics derived from GM engineering which have little to no history of safe use”,...

Botanicals extracted using super critical carbon dioxide extraction should not automatically be subject to new NDI filings, says the USP

Novel extraction method should not trigger automatic NDI notification, says USP

Botanical extracts that have been on the market for years should not automatically be treated as new dietary ingredients (NDIs) just because extraction methods have changed, according to the United...

NDI Draft Guidance Comments

Trade associations united in calls for ‘substantial overhaul’ of NDI draft guidance

The five main trade associations for the dietary supplements industry are united in their calls for a ‘timely’ and ‘substantial overhaul’ of the draft guidance, according to a joint statement.

"The Draft Guidance, in its current form, [...] is tantamount to obtaining FDA approval for dietary supplement products" Atrium
NDI Draft Guidance Comments in brief

Atrium Innovations on NDIs: The system isn’t broken, so why fix it?

The FDA’s NDI draft guidance sets up a ‘substantial and unprecedented premarket regulatory process’ that is ‘tantamount to obtaining FDA approval for dietary supplement products’, says Atrium Innovations.

NDI Draft Guidance Comments

UNPA: NDI draft guidance is ‘needlessly burdensome’ & does not advance overall safety of dietary supplements

The new dietary ingredient (NDI) draft guidance, as it stands, will not help achieve the objective of full and efficient implementation and enforcement of DSHEA, says the United Natural Products...

Emord: FDA has engaged in 'substantive new rulemaking'
NDI draft guidance comments

ANH-USA: 'Unworkable and irrational’ NDI guidance is rulemaking by the backdoor

Health advocacy group the Alliance for Natural Health USA (ANH-USA) is exploring all available “legal remedies” should the Food and Drug Administration (FDA) fail to ditch or substantially revise its...

NDI draft guidance comments

FDA history of safe use definition is ‘arbitrary and unfounded’, says pre/probiotics group

The International Scientific Association for Probiotics and Prebiotics (ISAPP) has urged the Food and Drug Administration (FDA) to rethink its approach to live microbial dietary ingredients.

Gormley: In the days ahead, we will be following up with 11 legislators whose offices we visited in order to ask for their support in calling on the FDA to withdraw the guidance and to hold a public hearing if it is not immediately withdrawn.”
NDI draft guidance comments

Citizens for Health NDI guidance withdrawal petition signatures approach 15,000

Health advocacy group Citizens for Health (CFH) has delivered a petition to the House of Representatives, the Senate and the Food and Food and Drug Administration (FDA) signed by more...

NDI draft guidance comments

AHPA to FDA: Tear up NDI draft guidance and start again

The Food and Drug Administration should tear up its “hugely flawed” draft guidance on new dietary ingredient (NDI) notifications and go back to the drawing board, according to the American...

NDI draft guidance comments

ABC: Expert panel should clarify list of grandfathered dietary ingredients

The Food and Drug Administration (FDA) should recognize the existing industry list of ‘grandfathered’ or ‘old’ dietary ingredients (ODIs) sold in the US pre-1994 – but work with an expert...

NDI draft guidance comments

CRN on NDI draft guidance: ‘A choir has many voices but we’re all singing the same song ‘

There will be differences in emphasis in comments submitted to the FDA on its draft guidance on new dietary ingredients (NDIs), but the overall message from the supplements industry is...

Trade to FDA: Don’t leave us in limbo on NDI guidance

While the Food and Drug Administration (FDA) will need time to process the expected tidal wave of comments on its draft guidance on new dietary ingredients (NDIs), the supplements industry...

Jarrow Formulas FOIA request on NDIs: ‘In sum, FDA has told us to drop dead’

Jarrow Formulas is still waiting for a “substantive response” from the Food and Drug Administration (FDA) to a Freedom of Information Act (FOIA) request submitted more than two months ago...

Proposed 2007 grandfathered date change: Limited chance of success and distraction from NDI comment deadline?

A proposed change to the date defining ‘grandfathered’ dietary ingredients to 2007 shows the industry there are options to the NDI issue, but it should not distract attention from FDA...

"There are obviously other programmatic areas that are important right now – adverse event reporting, the cGMPs – and these are critical." Dr Dan Fabricant, FDA

FDA on warning letters: ‘We are going to do more than just hand out paper’

The dietary supplements industry should keep an eye on GMP compliance, and not be distracted by discussions over NDIs, because enforcement may move beyond handing out paper if warning letters...

Herbalife: Six steps to improve functionality of NDI guidance

The functionality of the New Dietary Ingredient (NDI) guidance can be improved in only six steps, says direct selling giant Herbalife in its comments to the US Food and Drug...